Target intelligence / Profile preview

T cell receptor alpha variable 12-1 (TRAV12-1)

Target
TRAV12-1
Molecular classification
Receptor, Variable region of immunoglobulin superfamily, T cell receptor subunit
01

Overview

T cell receptor alpha variable 12-1 (TRAV12-1) is a variable region segment of the alpha chain of the T cell receptor heterodimer, which plays a critical role in the recognition of peptide–major histocompatibility complexes (pMHC) on antigen presenting cells[1][3][5]. This segment contributes to the enormous diversity of the T cell receptor repertoire, essential for adaptive immunity. The TCR complex, composed of alpha and beta (or delta and gamma) chains, recognizes antigens presented by MHC molecules, initiates downstream signaling (via the CD3 complex), and leads to T cell activation and proliferation[1][3]. TRAV12-1 is one of many variable gene segments that, through V(D)J recombination, allows T cells to recognize a vast array of pathogens. The specific role of TRAV12-1 is to provide part of the antigen-binding site unique to each T cell; variable region use can be relevant in immune responses, autoimmune disease, or lymphoid malignancies, although this particular variable gene is not a direct drug target[1][5][3].

Other names
T cell receptor alpha variable 12-1TRAV12-1TCRAV12S1TCRAV2S3TRAV121
02

Mechanism of action

Not directly targeted by any drugs; the potential mechanism would involve modulation of T cell receptor–mediated immune response (e.g., by monoclonal antibodies or immune modulators affecting the TCR complex as a whole)

03

Biological functions

Antigen recognitionSignal transductionImmune response
04

Disease associations

CancerInfectionInflammationAutoimmune diseases
05

Safety considerations

Autoimmunity (general risk if targeting TCRs broadly)Immunosuppression (general risk if targeting TCRs broadly)Cytokine release syndrome (general risk if targeting TCRs broadly)
06

Biomarkers

TCR repertoire profiling (including specific variable segment usage)

Beyond the preview

Go deeper on T cell receptor alpha variable 12-1 (TRAV12-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 12-1 (TRAV12-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call